Boston, MA -- (ReleaseWire) -- 01/23/2014 -- CytoSorbents Corporation (CytoSorbents) is a therapeutic device company. The company designs and develops blood purification technology to treat life-threatening illnesses. It also conducts clinical trials and develops adsorbent polymer technology to provide blood purification for acute and chronic health complications associated with blood toxicity. CytoSorbents' flagship technologies include BetaSorb, HemoDefend and CytoSorb. CytoSorbents' BetaSorb is used for the conduction of traditional high-flux hemodialysis treatment for the kidneys. The company's CytoSorb technology is under development stage, which is used to reduce the inflammatory mediators. Its HemoDefend is designed to improve the safety and quality of the blood supply. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the CytoSorbents Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.<\li> - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.<\li> - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.<\li> - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.<\li> - Data on relevant clinical trials and product patent details, wherever applicable.<\li> - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Get This Report
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.<\li>
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- BSD Medical Corporation (BSDM) - Product Pipeline Analysis, 2013 Update
- Volcano Corporation (VOLC) - Product Pipeline Analysis, 2013 Update
- Quidel Corporation (QDEL) - Product Pipeline Analysis, 2013 Update
- MicroPort Scientific Corporation (853) - Product Pipeline Analysis, 2013 Update
- Terumo Corporation (4543) - Product Pipeline Analysis, 2013 Update
- Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis, 2013 Update
- Edwards Lifesciences Corporation (EW) - Product Pipeline Analysis, 2013 Update
- Nipro Corporation (8086) - Product Pipeline Analysis, 2013 Update
- Corgenix Medical Corporation (CONX) - Product Pipeline Analysis, 2013 Update